oteseconazole

From Aaushi
Jump to navigation Jump to search
[1]

Indications

* for use in women not of reproductive potential

Dosage

  • 600 mg oteseconazole on day 1, 450 mg oteseconazole on day 2

Mechanism of action

  • oteseconazole inhibits CYP51, an fungal enzyme that preserves integrity of their cell walls

More general terms

References

  1. ↑ Marcus A FDA Approves Oteseconazole for Chronic Yeast Infections. Medscape. April 28, 2022 https://www.medscape.com/viewarticle/972882
Retrieved from "https://aaushi.info/w/index.php?title=A57597&oldid=1163587"